<?xml version="1.0" encoding="UTF-8"?>
<fig id="vaccines-08-00142-f003" orientation="portrait" position="float">
 <label>Figure 3</label>
 <caption>
  <p>Enforced replication activates innate and adaptive immune response upon VSV-EBOV infection. 
   <bold>A</bold>: Virus titers in LN 7 hours after 3 × 10
   <sup>6</sup> PFU i.v. VSV-EBOV infection. (
   <italic>n</italic> = 6). 
   <bold>B</bold>: Quantitative detection of VSV-NP in spleen and lymph node after infection as in 
   <bold>A</bold>. (
   <italic>n</italic> = 6–10). 
   <bold>C</bold>: Immunohistofluorescense staining of spleen sections of mice infected with 3 × 10
   <sup>6</sup> PFU VSV-EBOV i.v. 7 hours p.i. stained for Ebola virus GP (red) and CD169 (blue). Scale bar 100 µm. One representative picture show from each group of two independent experiments (
   <italic>n</italic> = 6). 
   <bold>D</bold>: IFNα serum levels of mice infected with 3 × 10
   <sup>6</sup> PFU VSV-EBOV i.v. 16 h p.i. (
   <italic>n</italic> = 6). 
   <bold>E</bold>,
   <bold>F</bold>: Relative expression of 
   <italic>Ifna4</italic> or 
   <italic>Ifnb1</italic> spleen (
   <bold>E</bold>, 
   <italic>n</italic> = 6–10)) or lymph node (
   <bold>F</bold>, 
   <italic>n</italic> = 6–10) obtained from infected mice as described in 
   <bold>A</bold>. (
   <italic>naïve</italic> WT mice 
   <italic>n</italic> = 4). 
   <bold>G:</bold> VSV-EBOV neutralizing antibodies in serum of mice i.v. infected with 3 × 10
   <sup>6</sup> PFU VSV-EBOV. (
   <italic>n</italic> = 6) * 
   <italic>p</italic> &lt; 0.05, ** 
   <italic>p</italic> &lt; 0.01, 
   <sup>#</sup>
   <italic>p</italic> &lt; 0.001 and 
   <sup>##</sup>
   <italic>p</italic> &lt; 0.0001 (Student’s t-test, 
   <bold>A</bold>,
   <bold>B</bold>,
   <bold>D</bold>,
   <bold>F</bold>), (Two-way-Anova, 
   <bold>G</bold>). Data are representative of two (
   <bold>A</bold>–
   <bold>G</bold>) experiments (mean ± SEM (
   <bold>A</bold>,
   <bold>B</bold>,
   <bold>D</bold>–
   <bold>G</bold>)).
  </p>
 </caption>
 <graphic xlink:href="vaccines-08-00142-g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
